Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Gelfand JM, Cree BAC, Hauser SL. Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis. Neurotherapeutics. 2017 Oct; 14(4):835-841.

2017
https://researcherprofiles.org/profile/1212867
28695471

Gelfand JM, Cree BAC, Hauser SL